Oxidative Phosphorylation
| Category | Biology |
|---|---|
| Also known as | Electron Transport Chain, OXPHOS, Respiratory Chain, ETC |
| Last updated | 2026-04-14 |
| Reading time | 7 min read |
| Tags | metabolismmitochondriaenergy-productionatpelectron-transport |
Overview
Oxidative phosphorylation (OXPHOS) is the metabolic process responsible for producing approximately 90% of the ATP generated by aerobic cells. Located in the inner mitochondrial membrane, this system couples the transfer of electrons from NADH and FADH2 (produced by the Krebs cycle, beta-oxidation, and other pathways) through a series of protein complexes to the pumping of protons across the membrane, creating an electrochemical gradient. This gradient drives ATP synthesis through ATP synthase in a process termed chemiosmotic coupling, first proposed by Peter Mitchell in 1961.
A single glucose molecule, fully oxidized through glycolysis, the Krebs cycle, and OXPHOS, can yield approximately 30-32 ATP — with OXPHOS accounting for 26-28 of those molecules.
Figure: Electron transport chain and chemiosmotic ATP synthesis
How It Works
The Electron Transport Chain
The electron transport chain (ETC) consists of four multiprotein complexes and two mobile electron carriers embedded in or associated with the inner mitochondrial membrane:
Complex I (NADH:ubiquinone oxidoreductase) — Accepts electrons from NADH, transferring them to ubiquinone (coenzyme Q10). Pumps 4 H+ across the membrane per NADH oxidized.
Complex II (Succinate dehydrogenase) — Accepts electrons from FADH2 (generated by succinate oxidation in the Krebs cycle) and passes them to ubiquinone. Does not pump protons.
Complex III (Cytochrome bc1 complex) — Accepts electrons from ubiquinol and transfers them to cytochrome c via the Q-cycle. Pumps 4 H+ per pair of electrons.
Complex IV (Cytochrome c oxidase) — Accepts electrons from cytochrome c and transfers them to molecular oxygen, forming water. Pumps 2 H+ per pair of electrons.
ATP Synthase (Complex V) — The proton gradient generated by complexes I, III, and IV drives H+ back through ATP synthase, which couples this flow to the phosphorylation of ADP to ATP. Approximately 4 H+ are needed per ATP synthesized.
Chemiosmotic Coupling
The pumping of protons from the matrix to the intermembrane space creates both a concentration gradient and an electrical potential (collectively, the proton-motive force). This stored energy is released as protons flow back through the Fo subunit of ATP synthase, driving rotation of the enzyme's catalytic F1 head to synthesize ATP.
Cardiolipin and Membrane Integrity
The inner mitochondrial membrane's unique phospholipid, cardiolipin, is essential for proper ETC function. Cardiolipin stabilizes the supercomplex assemblies formed by complexes I, III, and IV (known as respirasomes), optimizing electron transfer efficiency and minimizing reactive oxygen species (ROS) generation.
Key Components
- NADH and FADH2 — Electron donors from upstream metabolic pathways
- Ubiquinone (CoQ10) — Mobile lipid-soluble electron carrier between complexes I/II and III
- Cytochrome c — Mobile protein electron carrier between complexes III and IV
- Cardiolipin — The inner membrane phospholipid critical for supercomplex stability
- Oxygen — The terminal electron acceptor
Peptide Connections
Mitochondria-targeted peptides have become a significant area of research aimed at preserving or restoring OXPHOS function:
SS-31 (elamipretide) is a tetrapeptide that selectively binds cardiolipin in the inner mitochondrial membrane. By stabilizing cardiolipin-dependent interactions, SS-31 preserves respirasome assembly, improves electron transfer efficiency, and reduces pathological ROS generation. Preclinical and clinical studies have examined SS-31 in heart failure, mitochondrial myopathy, and age-related mitochondrial decline, where OXPHOS dysfunction is a central feature.
MOTS-c is a mitochondrial-derived peptide that modulates cellular energy metabolism through AMPK activation. While MOTS-c acts primarily on cytoplasmic metabolic pathways, its effects on metabolic homeostasis influence the substrate supply to OXPHOS. MOTS-c also appears to coordinate nuclear and mitochondrial genome communication, potentially affecting the expression of nuclear-encoded OXPHOS subunits.
Humanin is a 24-amino-acid peptide encoded in the mitochondrial genome that protects against cellular stress and apoptosis. Humanin has been shown to preserve mitochondrial membrane potential and prevent cytochrome c release from mitochondria — both of which are critical for maintaining OXPHOS function under stress conditions. Research has explored humanin in neurodegenerative and cardiovascular diseases where mitochondrial dysfunction plays a prominent role.
NAD+ precursors are relevant to OXPHOS because NAD+ serves as the primary substrate for Complex I. Age-related NAD+ depletion limits NADH availability and impairs electron flow through the chain. Strategies to boost NAD+ levels aim to restore the electron donor pool needed for optimal OXPHOS throughput.
Clinical Significance
OXPHOS dysfunction underlies a broad spectrum of human diseases. Primary mitochondrial diseases caused by mutations in mitochondrial or nuclear DNA-encoded OXPHOS subunits affect an estimated 1 in 5,000 individuals, presenting with myopathy, encephalopathy, lactic acidosis, and multisystem failure.
Acquired OXPHOS impairment is increasingly recognized in aging, neurodegeneration (Alzheimer's and Parkinson's diseases), heart failure, metabolic syndrome, and cancer. In aging, cumulative oxidative damage to mitochondrial DNA and cardiolipin reduces OXPHOS efficiency, creating a vicious cycle of increased ROS production and further damage.
In cancer, many tumors exhibit altered OXPHOS function, with some relying more on glycolysis (Warburg effect) and others paradoxically upregulating OXPHOS for survival.
Related Topics
- Krebs Cycle — Produces NADH and FADH2 that feed the electron transport chain
- Mitochondrial Function — Broader overview of mitochondrial biology
- SS-31 — Cardiolipin-targeting peptide that stabilizes OXPHOS machinery
- MOTS-c — Mitochondria-derived metabolic regulator
- Humanin — Mitochondria-derived cytoprotective peptide
Related entries
- Krebs Cycle— The Krebs cycle is the central metabolic hub within mitochondria that oxidizes acetyl-CoA derived from carbohydrates, fats, and proteins to generate electron carriers for ATP production.
- Humanin— A 24-amino-acid mitochondrial-derived peptide encoded within the 16S ribosomal RNA gene of mitochondrial DNA, the first MDP discovered, studied extensively for its neuroprotective, anti-apoptotic, and cytoprotective properties across multiple organ systems.
- MOTS-c— A 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA gene of mitochondrial DNA, identified as an exercise mimetic that activates AMPK signaling and regulates metabolic homeostasis.
- SS-31 (Elamipretide)— A synthetic mitochondria-targeted tetrapeptide that selectively binds cardiolipin in the inner mitochondrial membrane, stabilizing electron transport chain function — the most clinically advanced mitochondria-targeted peptide, with Phase III trial data in Barth syndrome and heart failure.
- Mitochondrial Function— Mitochondrial function encompasses the energy-producing, signaling, and quality-control processes within mitochondria, including oxidative phosphorylation, ROS management, apoptosis regulation, and the emerging biology of mitochondrial-derived peptides.